Deborah Dunsire Name of Recipient 200,000 Number of Restricted Shares of Common Stock AwardedRestricted Stock Agreement • August 8th, 2005 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.7 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. July 20, 2005 Jack Dean President, U.S. Science & Medical Affairs Aventis Pharmaceuticals Inc., a member of the...Collaboration and License Agreement • August 8th, 2005 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations
